Previous 10 | Next 10 |
home / stock / mkgaf / mkgaf news
MERCK Kommanditgesellschaft auf Aktien. (MKGAF) Q1 2021 Results Earnings Conference Call May 12, 2021, 08:00 AM ET Company Participants Constantin Fest - Head-Investor Relations Marcus Kuhnert - Group Chief Financial Officer Kai Beckmann - Chief Executive Officer, Electronics Business Sector ...
The following slide deck was published by MERCK Kommanditgesellschaft auf Aktien in conjunction with their 2021 Q1 earnings call. For further details see: MERCK Kommanditgesellschaft auf Aktien 2021 Q1 - Results - Earnings Call Presentation
Merck KGaA (not to be confused with the U.S.-based Merck) saw its EPS increase by 50% in 2020. The company is guiding for another year of EBITDA growth in 2021. As the capex will remain virtually unchanged, this should result in a 10% increase in the free cash flow result. Gre...
Exelixis (EXEL) announced a collaboration with Pfizer (PFE) and Merck KGaA (MKGAF) in an ongoing phase 1b dose-escalation study, STELLAR-001 for XL092, the company’s oral tyrosine kinase inhibitor targeting cancer growth and spread.Under the agreement, three new cohorts will ...
Merck KGaA (MKKGY) will invest 25M Euros (~$29.8M) to add a production unit at a facility in Molsheim, France, for the manufacture of COVID-19 and other vaccines.The new unit should be operational by the end of the year.Merck KGaA's (MKGAF) American counterpart previously announced it will he...
Merck KGaA (MKGAF) announces topline data from the Phase II INTR@PID BTC 047 study evaluating bintrafusp alfa as a monotherapy in the second-line treatment of patients with biliary tract cancer ((BTC)) who have failed or are intolerant of first-line platinum-based chemotherapy. In the study o...
Merck KGaA, Darmstadt, Germany, Reports Topline Data for Bintrafusp Alfa as Second-Line Monotherapy Treatment in Biliary Tract Cancer PR Newswire Not intended for UK-based media DARMSTADT, Germany , March 16, 2021 /PRNewswire/ -- Merck KG...
BioNTech (BNTX), the partner of Pfizer (PFE) in COVID-19 vaccine development has enlisted as many as 13 companies in forming a new manufacturing alliance aimed at accelerating the deliveries of its messenger-RNA based COVID-19 shot, the Wall Street Journal reports.BioNTech, which has com...
MERCK Kommanditgesellschaft auf Aktien (MKGAF) Q4 2020 Earnings Conference Call March 04, 2021 08:00 AM ET Company Participants Constantin Fest - Head-Investor Relations Stefan Oschmann - Group Chief Executive Officer Marcus Kuhnert - Group Chief Financial Officer Kai Beckmann - Chief Executi...
The following slide deck was published by MERCK Kommanditgesellschaft auf Aktien in conjunction with their 2020 Q4 earnings call. For further details see: MERCK Kommanditgesellschaft auf Aktien 2020 Q4 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Merck Kgaa Company Name:
MKGAF Stock Symbol:
OTCMKTS Market:
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...